A different physiology means a different withdrawal — and a different risk profile.
Substances act on different receptor systems in the brain, and the body adapts to each in different ways. When the substance is removed, the adaptation reveals itself as withdrawal. The shape of that withdrawal — physical, psychological, dangerous, painful — depends on which receptor systems were involved and how deeply the body had reorganised around them.
A useful framing: opioids hijack the body’s natural pain-relief and reward systems, so withdrawal floods every channel that used to be quiet. Benzodiazepines and alcohol act on the same inhibitory GABA system, so withdrawal is medically dangerous in the same way. Cocaine acts on dopamine, so withdrawal is largely psychological — but the psychological collapse is severe enough that suicide risk is elevated. Cannabis and prescription drugs sit between these poles in ways that families consistently underestimate.
Heroin, smack, tramadol, codeine, prescription opioids.
Opioid withdrawal is the most physically distressing of the common withdrawals, but it is rarely medically dangerous in an otherwise healthy adult. The clinical priority is comfort and retention — keeping the patient engaged through the worst window so they do not relapse to escape it.
Onset and timeline
- 6–12 hours after last short-acting dose (heroin, smack): early symptoms begin
- 24–72 hours: peak symptom intensity — flu-like, painful, exhausting
- Day 4–7: acute symptoms subside; sleep and appetite begin to return
- Week 2–4: post-acute withdrawal — low mood, cravings, fatigue
- Long-acting opioids (methadone, buprenorphine): timeline shifts later by days
What families will see
- Profuse sweating, watery eyes, runny nose, yawning
- Severe muscle and bone aches; restless legs, inability to sit still
- Vomiting, diarrhoea, abdominal cramps; significant fluid loss
- Insomnia despite exhaustion; anxiety and irritability
- Goosebumps and dilated pupils — visible physical signs
How medical care manages it
The standard protocol uses buprenorphine (or in some cases methadone) on a tapering schedule, plus medications for nausea, sleep, anxiety, and muscle pain. Hydration is continuous because vomiting and diarrhoea cause significant fluid loss. The clinical goal is to keep the patient comfortable enough to remain in treatment — most relapses to opioids happen because the patient is escaping the unmanaged withdrawal, not because they want to use.
A psychological collapse hidden inside what looks like depression.
Cocaine withdrawal is unusual because it is largely psychological. The body does not produce the dramatic physical signs of opioid withdrawal, and families often think the patient is "just depressed" or "just tired". They are not — they are in withdrawal from a substance that hijacks dopamine reward systems, and the crash that follows is steep enough to carry meaningful suicide risk.
Timeline and pattern
- First 24 hours: profound exhaustion, hypersomnia, increased appetite
- Day 1–3: acute crash — low mood, irritability, anhedonia (inability to feel pleasure)
- Week 1–2: cravings spike unpredictably, often triggered by sights and routines
- Week 3–8: peak relapse window — the "wall" — when motivation feels lowest
- Beyond week 8: cravings reduce in frequency and intensity but do not vanish
Why medical care matters anyway
There is no specific pharmacotherapy for cocaine withdrawal in the way there is for opioids or alcohol. What medical care provides is psychiatric monitoring during the crash window — particularly for suicide risk — sleep support, structured therapy that begins immediately rather than after detox, and the relapse-prevention scaffolding that the eight-week "wall" makes essential.
A real withdrawal that families and patients consistently dismiss.
Cannabis withdrawal is real, clinically recognised, and reliably underestimated — in part because the substance is widely framed as non-addictive. For daily long-term users, abstinence produces a recognisable withdrawal syndrome that is uncomfortable enough to drive relapse if not anticipated.
Symptoms families will see
- Sleep disruption and vivid, often disturbing dreams (most common and persistent)
- Loss of appetite and weight loss in the first week
- Irritability, anxiety, restlessness, low mood
- Headaches, sweating, mild tremor
- Cravings, particularly in the evenings and around old use settings
Timeline
Symptoms begin within twenty-four to seventy-two hours of last use, peak between days two and six, and largely resolve over two to three weeks. Sleep disturbance often persists longer. Medical care is supportive — sleep support, anxiety management, structured therapy — rather than pharmacological in the way opioid detox is.
The most underestimated dangerous withdrawal in Indian practice.
Benzodiazepine withdrawal — alprazolam, diazepam, clonazepam, lorazepam — is among the most medically dangerous withdrawals in clinical addiction medicine, and is consistently underestimated because the medications themselves are commonly prescribed. Withdrawal can cause seizures and a medically unstable state similar to alcohol withdrawal, because both substances act on the same GABA system.
What makes it dangerous
- Long-term daily use down-regulates GABA; abrupt withdrawal causes hyperexcitability
- Withdrawal seizures can occur, particularly with high-dose or short-acting agents (alprazolam)
- Anxiety, panic, and insomnia rebound severely — often worse than baseline
- Perceptual disturbances, depersonalisation, and protracted withdrawal can persist for weeks
- Cold-turkey discontinuation is contraindicated for daily long-term users
The standard medical protocol involves cross-tapering to a longer-acting benzodiazepine and reducing dose slowly over weeks rather than days. The pace is patient-specific. This is one of the few withdrawals where doing it slowly under medical supervision is dramatically safer than doing it quickly.
Tramadol, codeine, alprazolam, zolpidem — dependency that started inside a prescription.
Prescription drug dependency is among the fastest-growing patterns in Indian addiction medicine, and is often the slowest to be recognised because the substance arrived through a legitimate medical channel. Tramadol and codeine produce opioid withdrawals; alprazolam and zolpidem produce benzodiazepine-pattern withdrawals. The risk profiles match the underlying chemistry, not the prescription form.
Tapering schedules for prescription drug dependency are individualised: dose, duration of use, and whether multiple agents are in play all shape the protocol. The clinical priorities are the same as for the corresponding street substances — comfort, safety, and seamless transition into structured therapy.
Why "we’ll just stop at home" usually doesn’t work.
Most patients who present to our admissions desk have already attempted home detox at least once. The conversations follow a recognisable arc: the patient stopped, the first day was manageable, the second day was hard, the third day produced symptoms severe enough to relapse — and the family interpreted the relapse as a failure of willpower. It is rarely that. Three structural reasons make home detox unreliable.
- No pharmacological bridge — the body has nothing to soften the transition the substance was masking
- No environmental separation — the same triggers, same people, same routines that sustained use are still present
- No clinical safety net — for alcohol and benzodiazepines specifically, the medical risk is real and unsupervised
Medical detox is not a moral upgrade on home detox. It is a different intervention. It changes the physiology, the environment, and the safety architecture all at once — which is why it works where home detox keeps failing.